{"disease":{"id":"essential-fatty-acid-deficiency","name":"essential fatty acid deficiency"},"drugs":{"marketed":[{"drug_id":"soybean-oil","indication_name":"Essential Fatty Acid Deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SOYBEAN OIL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid Emulsion [EPC]","quality_score":30,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03555019","title":"Nutrition Therapy in the Immature Infant (ImNuT)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":121,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT04555044","title":"Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Baxter Healthcare Corporation","has_results":true},{"nct_id":"NCT06274788","title":"Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Fresenius Kabi","has_results":false},{"nct_id":"NCT04807478","title":"Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Fresenius Kabi","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}